Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
2001 Jan 12;280(1):132-8
Urology (2008) Clinical trial of intranasal PT-141 in men with ED non-responsive to sildenafil Clavell, H.L., et al
& Lebwohl, M
Unknown long-term safety
Complementary approaches may include: Behavioral therapy or weight management counseling Sleep optimization (79 hours nightly) Stress management techniques Evaluation and treatment of coexisting conditions (insulin resistance, sleep apnea, depression) FDA-approved oral weight loss medications (orlistat, phentermine/topiramate ER, naltrexone/bupropion) as alternatives to injectables (note: phentermine monotherapy is approved for short-term use only) Patients should maintain realistic expectationsweight loss may be slower with hypothyroidism, even when well-controlled
US$ 26.62
US$ 28.65
US$ 26.42
US$ 23.60
US$ 23.11
US$ 27.86
US$ 23.79
